Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300233.SZ

HOLDREMOVE

Shandong Jincheng Pharmaceutical Group Co., Ltd · Basic Materials · China · $745M · Avg Vol: $15M/d

60
StockRank
Q
61
V
48
M
39
P/E (TTM)
68.8x
ROE
1.7%
D/E
0.1x
Dividend %
2.0%
AI CONVICTION THESIS

Shandong Jincheng operates in the API and pharmaceutical chemical space, but it lacks the scale, regulatory moat, and high-value biologics capabilities of the leading global CDMOs that we target.

COMPANY DESCRIPTION

Shandong Jincheng Pharmaceutical Group Co., Ltd. is a leading manufacturer of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosages, with a global leadership position in cephalosporin side-chain intermediates. The company also produces specialty chemicals and biological products, such as glutathione. Its competitive moat is established through its vertically integrated chemical synthesis platforms, cost leadership in key intermediates, and a diversified global customer base.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue518M523M499M404M-7.9%
EPS0.100.070.080.02-44.7%
Shares387M384M384M384M-0.9%
Debt96M82M76M56M-16.5%
Equity533M549M557M541M0.5%
Op CF38M98M44M47M7.7%
Inv CF-53M-46M-12M-23M
Fin CF565,963-36M-36M-44M
Loading...
PRICE (1M)-21.1%
1.771.922.082.232.38May 8May 29Jun 18
SMA 50SMA 200
Close
$1.87
RSI (14)
42.6
52W High
$3.27
From 52W High
0.6%

SCORE BREAKDOWN

Quality
61
ROIC
2.2%43.6
ROE
1.7%42.8
GP/Assets
18.1%66.4
Op. Margin
11.4%69.4
FCF/Assets
7.0%82.5
Piotroski
81.2
Int. Cover
8.2x60.5
D/E Ratio
0.09x69.9
Current Ratio
1.73x41.4
Value
48
P/E (TTM)
68.8x16.2
EV/EBITDA
9.5x41.7
P/FCF
93.8x66.0
P/B
1.3x66.7
P/S
1.7x48.9
Div Yield
2.0%58.2
Momentum
39
52W High %
57%21.9
RS 6M
-31%23.4
SMA 50/200
0.91x16.8
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
96.6
Q Growth
65%64.4

FUNDAMENTALS

Market Cap
$745M
P/E (Forward)
6.7x
Gross Margin
33.9%

SECTOR PEERS

Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of 300233.SZ are excluded.

TickerCompanyMkt CapStockRankSignal
300233.SZShandong Jincheng Pharmaceutical Group Co., Ltd(you)$745M60HOLD
688758.SSSuzhou Sepax Technologies Co., Ltd.$1.1B58HOLD
605183.SSQuechen Silicon Chemical Co., Ltd.$993M56HOLD
300121.SZShandong Yanggu Huatai Chemical Co., Ltd.$726M49HOLD
603004.SSZhejiang Dragon Technology Co., Ltd.$659M49HOLD
2198.HKChina Sanjiang Fine Chemicals Company Limited$497M51HOLD
002637.SZZanyu Technology Group Co., Ltd.$754M43HOLD
600367.SSGuizhou RedStar Developing Co.,Ltd.$1.6B57HOLD
002167.SZGuangdong Orient Zirconic Ind Sci & Tech Co.,Ltd$1.5B56HOLD
002125.SZXiangtan Electrochemical Scientific Co.,Ltd$1.4B54HOLD

Peer medians: ROE 6.2% · P/E 33.1x · Gross margin 17.5%

Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) — Stock Score Summary

Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) has a MoatMap StockRank of 60/100 based on Quality (61/100), Value (48/100), and Momentum (39/100) factor scores. The current signal is HOLD. Shandong Jincheng operates in the API and pharmaceutical chemical space, but it lacks the scale, regulatory moat, and high-value biologics capabilities of the leading global CDMOs that we target.

Shandong Jincheng Pharmaceutical Group Co., Ltd. is a leading manufacturer of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosages, with a global leadership position in cephalosporin side-chain intermediates. The company also produces specialty chemicals and biological products, such as glutathione. Its competitive moat is established through its vertically integrated chemical synthesis platforms, cost leadership in key intermediates, and a diversified global customer base.

Key Financial Metrics

Price$1.87
Market Cap$745M
P/E (TTM)68.78
P/E (Forward)6.73
Price/Book1.26
Return on Equity1.7%
Return on Invested Capital2.2%
Debt/Equity8.89
Gross Margin33.9%
Operating Margin11.4%
Revenue Growth3.9%
Dividend Yield2.0%
Free Cash Flow$8M

Shandong Jincheng Pharmaceutical Group Co., Ltd operates in the Chemicals industry, part of the Basic Materials sector (China).

Frequently Asked Questions

What is Shandong Jincheng Pharmaceutical Group Co., Ltd’s (300233.SZ) StockRank?
MoatMap’s StockRank for Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) is 60/100, with a Hold signal. It is a composite of Quality (61), Value (48), and Momentum (39) factor ranks across MoatMap’s 20,000+ stock universe.
Does Shandong Jincheng Pharmaceutical Group Co., Ltd have an economic moat?
Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) has a Quality factor score of 61/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shandong Jincheng Pharmaceutical Group Co., Ltd a buy, hold, or sell?
MoatMap’s current signal for Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) is Hold, based on a StockRank of 60/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shandong Jincheng Pharmaceutical Group Co., Ltd in?
Shandong Jincheng Pharmaceutical Group Co., Ltd (300233.SZ) operates in the Basic Materials sector, specifically the Chemicals industry (China).